CJC-1295 (Without DAC) 5mg – High-Purity Research Peptide for Laboratory Applications

CJC-1295 (Without DAC) 5mg is a synthetic peptide compound widely referenced in controlled laboratory research environments. Designed without Drug Affinity Complex (DAC), this format allows researchers to examine short-duration activity profiles under structured experimental conditions. Supplied as a lyophilized (freeze-dried) powder, the compound is intended strictly for scientific and analytical use.

In modern peptide research, precision matters. From molecular stability to receptor interaction behavior, each structural detail plays a role in how a compound performs in a research model. CJC-1295 (Without DAC) is commonly studied in experimental settings focused on growth hormone–releasing hormone (GHRH) receptor pathways and related signaling mechanisms.

Product Specifications

• Compound Name: CJC-1295 (Without DAC)

• Molecular Format: Synthetic peptide sequence

• Quantity: 5mg per sterile vial

• Form: Lyophilized powder

• Grade: Laboratory research standard

• Storage Conditions: 2–8°C (refrigerated)

• Intended Use: For laboratory research and analytical purposes only

Each vial is sealed to maintain integrity during transport and storage. Lyophilization enhances stability, allowing the compound to remain structurally consistent when handled according to recommended laboratory procedures.

Structural Overview and Research Context

CJC-1295 (Without DAC) is a modified peptide analog studied for its interaction with GHRH receptors in non-clinical models. The “Without DAC” designation refers to the absence of Drug Affinity Complex, which results in a shorter active window compared to DAC-modified versions. Because of this difference, researchers often select the non-DAC format when investigating acute signaling responses, receptor binding kinetics, and time-dependent pathway modulation.

In controlled laboratory environments, peptide stability, solubility behavior, and degradation patterns are important evaluation criteria. CJC-1295 (Without DAC) is typically examined in vitro or in non-human experimental systems where researchers can observe biochemical pathway engagement under defined variables.

Common Research Applications

Within compliant laboratory settings, CJC-1295 (Without DAC) may be referenced in studies involving:

• Receptor-binding interaction analysis

• Signal transduction pathway modeling

• Short-duration exposure experiments

• Peptide stability and degradation research

• Controlled biochemical response mapping

Its shorter half-life profile compared to DAC-containing formats allows researchers to assess rapid-response mechanisms without prolonged systemic exposure in experimental models.

Quality Control and Laboratory Handling

To ensure research reliability, each production batch undergoes verification processes to confirm identity and purity in accordance with laboratory-grade standards. Maintaining strict storage and handling protocols is essential for preserving structural integrity.

Recommended handling practices include:

• Storage at refrigerated temperatures (2–8°C)

• Avoiding repeated freeze-thaw cycles

• Use of sterile laboratory techniques during reconstitution

• Proper labeling and documentation for traceability

All research activities involving peptide compounds should be conducted by qualified professionals in controlled laboratory environments.

Stability and Storage Guidelines

Peptide compounds are sensitive to environmental conditions such as heat, moisture, and light exposure. The lyophilized format helps minimize degradation prior to reconstitution. For optimal stability:

• Store unopened vials refrigerated

• Protect from direct light exposure

• Ensure airtight sealing after handling

• Use appropriate laboratory-grade solvents if reconstitution is required

Long-term stability depends on consistent environmental control and proper laboratory protocol adherence.

Compliance and Intended Use Statement

CJC-1295 (Without DAC) 5mg is supplied strictly for laboratory research, analytical testing, and scientific investigation. This product is not intended for human consumption, medical use, therapeutic application, or diagnostic procedures. It is not classified as a pharmaceutical drug and has not been evaluated by regulatory authorities for clinical use.

Purchase of this product implies acknowledgment that the buyer is a qualified professional or research institution operating within applicable laws and regulations.

Why Researchers Select the Non-DAC Format

When studying peptide behavior, duration of activity can significantly influence experimental outcomes. The non-DAC version of CJC-1295 provides a shorter active profile, which may be preferred in research models designed to evaluate immediate receptor interactions and acute biochemical responses.

This distinction makes it particularly relevant in experimental frameworks where prolonged binding affinity is not required. Researchers seeking time-controlled evaluation parameters frequently explore this specific format.

Packaging and Documentation

Each vial is clearly labeled with batch identification details to support research traceability. Documentation may include:

• Batch number

• Net content (5mg)

• Storage recommendations

• Laboratory-use disclaimer

Proper record-keeping is essential in all research settings to maintain study reproducibility and regulatory alignment.

Final Notice

This compound is provided exclusively for laboratory research purposes. It is not approved for human or veterinary use. Any use outside of controlled research environments is strictly prohibited.